A novel reduced intensity regimen for allogeneic hematopoietic stem cell transplantation associated with a reduced incidence of graft-versus-host disease.
about
Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T-cell lymphomaExtracorporeal photopheresis combined with pentostatin in the conditioning regimen for canine hematopoietic cell transplantation does not prevent GVHD.Autologous apoptotic cells preceding transplantation enhance survival in lethal murine graft-versus-host models.Pentostatin - pharmacology, immunology, and clinical effects in graft-versus-host disease.Blood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associatedThe pentostatin plus cyclophosphamide nonmyeloablative regimen induces durable host T cell functional deficits and prevents murine marrow allograft rejection.Guidelines on the use of extracorporeal photopheresisAn anti-human thymocyte globulin-based reduced-intensity conditioning regimen is associated with a higher quality of life and lower organ toxicity without affecting lymphocyte reconstitutionPentostatin plus cyclophosphamide safely and effectively prevents immunotoxin immunogenicity in murine hosts.Extracorporeal photopheresis in addition to pentostatin in conditioning for canine hematopoietic cell transplantation: role in engraftment.Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation.Acute graft versus host disease.High-Dose Sirolimus and Immune-Selective Pentostatin plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor Responses.Phase II study of CD4+-guided pentostatin lymphodepletion and pharmacokinetically targeted busulfan as conditioning for hematopoietic cell allografting.Reduced-intensity conditioning for acute myeloid leukemia: is this strategy correct.Combination Therapy for Graft-versus-Host Disease Prophylaxis with Etanercept and Extracorporeal Photopheresis: Results of a Phase II Clinical Trial.Extracorporeal photopheresis in graft-versus-host disease.U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease.Reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia.Earlier may be better: the role of extracorporeal photopheresis (ECP) as prevention of GVHD after allogeneic transplant.
P2860
Q24200183-D4BB1D54-1918-48FD-8B9D-4DDA891DDE42Q34135339-6E3249E6-F41E-4C40-9247-CD60BA6C95D7Q34170406-DDA5A555-CD01-482B-9DE4-966071CE4A3BQ34372234-9EDCAFED-12B1-48A2-A6A8-0E7AF88AA379Q34626390-42F4766B-FF9B-497B-9AB9-DB3E8E8F2BBFQ34700443-EA5351CF-8E97-4711-A10A-D680C222F106Q34918643-93DC5830-A794-489D-9B06-080CC06F1DD7Q34989247-23DFB631-C002-4CF6-9419-A56DCA56E865Q35023967-87735E8A-D6C5-4619-990A-43C8BE1B2E85Q35050513-0D390065-19DB-440E-97BE-57D054056794Q36036186-1DD91EC8-D3B8-4374-9904-8E97CB384E71Q36059671-056D2E3C-B1ED-4857-8B1B-6B9D13E9D1D6Q36117735-3B301204-A309-4A7A-A2A1-364F1F74C6D1Q36341861-CADA5561-9C3F-4F95-A021-DE798D682AC9Q36548370-5D6388D2-37F4-4C7C-B42B-19E6A50B2A80Q36821646-6815E364-52A6-4D24-BA7C-0BEB0B472FFAQ37051405-3E178341-914F-4C9C-B4A4-443DE924E3D7Q37074253-99020B58-5847-4DA8-BE0A-62143C5B7E57Q37159533-942857FA-A8F7-46BC-96DE-F5FEF89E77D5Q53109642-BDCE4FD0-0DD3-433C-84F8-11DCCD1ABEE4
P2860
A novel reduced intensity regimen for allogeneic hematopoietic stem cell transplantation associated with a reduced incidence of graft-versus-host disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
A novel reduced intensity regi ...... of graft-versus-host disease.
@en
A novel reduced intensity regi ...... of graft-versus-host disease.
@nl
type
label
A novel reduced intensity regi ...... of graft-versus-host disease.
@en
A novel reduced intensity regi ...... of graft-versus-host disease.
@nl
prefLabel
A novel reduced intensity regi ...... of graft-versus-host disease.
@en
A novel reduced intensity regi ...... of graft-versus-host disease.
@nl
P2093
P2860
P356
P1476
A novel reduced intensity regi ...... of graft-versus-host disease.
@en
P2093
D Lawrence
D P Schenkein
K B Miller
T F Roberts
P2860
P2888
P304
P356
10.1038/SJ.BMT.1704454
P407
P577
2004-05-01T00:00:00Z